CORE--BIOSPECIMENS

$0P50FY2002CANIH

University Of Iowa, Iowa City IA

Investigators

Linked publications & trials

Paper 39418117 Paper 39384745 Paper 39352751 Paper 39321424 Paper 39117654 Paper 38991126 Paper 38902256 Paper 38852069 Paper 38713887 Paper 38669353 Paper 38654668 Paper 38633575 Paper 38409747 Paper 38271621 Paper 38180317 Paper 37957158 Paper 37698994 Paper 37646653 Paper 37633531 Paper 37603594 Paper 37591873 Paper 37308177 Paper 37307169 Paper 37254453 Paper 37193683 Paper 37117318 Paper 36735908 Paper 36516079 Paper 36495588 Paper 36418344 Paper 36305717 Paper 36291813 Paper 36273105 Paper 36207110 Paper 36057138 Paper 36055310 Paper 35969843 Paper 35941721 Paper 35849723 Paper 35802834 Paper 35793440 Paper 35661109 Paper 35617689 Paper 35615932 Paper 35594505 Paper 35586895 Paper 35580285 Paper 35504884 Paper 35483398 Paper 35390145 Paper 35358443 Paper 35244686 Paper 35175355 Paper 35169244 Paper 34987165 Paper 34978715 Paper 34897961 Paper 34886888 Paper 34787457 Paper 34782394 Paper 34662895 Paper 34622145 Paper 34285341 Paper 34274939 Paper 34270795 Paper 34267181 Paper 34230608 Paper 34226281 Paper 34214199 Paper 34157780 Paper 34125579 Paper 34121594 Paper 34110453 Paper 34083419 Paper 33997638 Paper 33971040 Paper 33961018 Paper 33859327 Paper 33829216 Paper 33712566 Paper 33690107 Paper 33661547 Paper 33657788 Paper 33644854 Paper 33639170 Paper 33615552 Paper 33539584 Paper 33529046 Paper 33507295 Paper 33451977 Paper 33414416 Paper 33338288 Paper 33168821 Paper 33140103 Paper 33066142 Paper 33047636 Paper 33021136 Paper 32985015 Paper 32763516 Paper 32744316

Abstract

The goal of the University of Iowa/Mayo Clinic Lymphoma (UI/MC Lymphoma SPORE) Developmental Research Program is to support innovative, scientifically sound projects that investigate a question pertaining to translational lymphoma research. The Developmental Research Program will provide up to $50,000 for one year ($25,000 from SPORE funds and a matching $25,000 from institutional resources) to each of six projects. There will be the possibility of a second year of support based on progress. It is anticipated that support of developmental research projects will result in the generation of new hypotheses that will be tested in full UI/MC Lymphoma SPORE-sponsored projects or through peer reviewed external grant support. The long-term goal of the UI/MC Lymphoma SPORE program is to translate the findings generated by developmental projects into a reduction in the incidence and mortality rates of lymphoma. More specifically, the objectives of the Developmental Research Program are to: (1) encourage innovative translationally-relevant laboratory, population and clinical studies; (2) foster extensive collaboration between basic science, population science and clinical disciplines in translational research in lymphoma; and (3) generate new hypotheses to be tested in large-scale research projects or clinical trials that may lead to significant reduction of lymphoma incidence and mortality. Brief outlines of ten potential development research projects from investigators at the University of Iowa and the Mayo Clinic are included to demonstrate the depth and breath of ongoing research that can be applied to the translational lymphoma research at these institutions and could be eligible for UI/MC Lymphoma SPORE Developmental Program support.

View original record on NIH RePORTER →